...
【24h】

Fetal RhD genotyping by analysis of maternal blood. A case report.

机译:通过分析母体血液对胎儿RhD进行基因分型。病例报告。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Prenatal determination of fetal rhesus D (RhD) status is desirable in pregnancies in sensitized, RhD-negative women to prevent hydropic degeneration of the fetus. Recently, a polymerase chain reaction (PCR) test on amniocytes or chorionic villi has been in use to demonstrate the RhD status of the fetus in sensitized pregnancies. A more advisable, noninvasive approach is to determine the fetal RhD group from fetal cells circulating in maternal blood. CASE: We report on a prenatal diagnosis where RhD-positive cells could be detected from peripheral blood of a sensitized, RhD-negative mother. The presence of an RhD-positive fetus was confirmed by subsequent amplification of fetal DNA obtained by chorionic villus biopsy. CONCLUSION: In sensitized pregnancies, the number of fetal cells in maternal blood seems to be high enough to be detected by PCR in every case.
机译:背景:对于致敏的,RhD阴性的女性,怀孕前需要对胎儿的恒河猴D(RhD)状况进行产前确定,以防止胎儿发生水样变性。最近,对羊膜细胞或绒毛膜绒毛的聚合酶链反应(PCR)测试已用于证明致敏妊娠胎儿的RhD状况。一种更可取的非侵入性方法是从母体血液中循环的胎儿细胞中确定胎儿RhD组。病例:我们报告了产前诊断,其中可以从致敏的RhD阴性母亲的外周血中检测到RhD阳性细胞。 RhD阳性胎儿的存在通过绒毛膜绒毛活检获得的胎儿DNA的后续扩增得到证实。结论:在致敏妊娠中,母体血液中的胎儿细胞数量似乎足够高,可以在每种情况下通过PCR进行检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号